EU and Chinese Taipei continue co-operation talks
This article was originally published in Clinica
Executive Summary
A delegation of four high-ranking officials from the Chinese Taipei will attend the European Commission Medical Device Expert Working Group meeting, which is being held on March 29 and 30 in Brussels. Half a day is being reserved for the visiting delegation to explain their medical devices regulatory system to the EU member state, industry and Commission experts present at the meeting and to give them the opportunity to explain what they expect from the EU/Chinese Taipei co-operation.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.